Simplified Model of Linkage and Retention to Care, Using a Mobile Unit and a Same-day Test and Treat Approach Among Excluded Population. (SIMPLIFIED)

Condition:   HIV Infections Intervention:   Drug: Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY] Sponsor:   Fundacion SEIMC-GESIDA Not yet recruiting

Source: ClinicalTrials.gov - June 6, 2022 Category: Research Source Type: clinical trials